Literature DB >> 30842263

Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems.

Rachel J Harding1, Peter Loppnau2, Suzanne Ackloo2, Alexander Lemak3, Ashley Hutchinson2, Brittany Hunt2, Alex S Holehouse4, Jolene C Ho2, Lixin Fan5, Leticia Toledo-Sherman6, Alma Seitova2, Cheryl H Arrowsmith7,3.   

Abstract

The gene mutated in individuals with Huntington's disease (HD) encodes the 348-kDa huntingtin (HTT) protein. Pathogenic HD CAG-expansion mutations create a polyglutamine (polyQ) tract at the N terminus of HTT that expands above a critical threshold of ∼35 glutamine residues. The effect of these HD mutations on HTT is not well understood, in part because it is difficult to carry out biochemical, biophysical, and structural studies of this large protein. To facilitate such studies, here we have generated expression constructs for the scalable production of HTT in multiple eukaryotic expression systems. Our set of HTT expression clones comprised both N- and C-terminally FLAG-tagged HTT constructs with polyQ lengths representative of the general population, HD patients, and juvenile HD patients, as well as the more extreme polyQ expansions used in some HD tissue and animal models. Our expression system yielded milligram quantities of pure recombinant HTT protein, including many of the previously mapped post-translational modifications. We characterized both apo and HTT-HTT-associated protein 40 (HAP40) complex samples produced with this HD resource, demonstrating that this toolkit can be used to generate physiologically meaningful HTT complexes. We further demonstrate that these resources can produce sufficient material for protein-intensive experiments, such as small-angle X-ray scattering, providing biochemical insight into full-length HTT protein structure. The work outlined and the tools generated here lay a foundation for further biochemical and structural work on the HTT protein and for studying its functional interactions with other biomolecules.

Entities:  

Keywords:  Huntington disease; biophysics; molecular dynamics; neurodegeneration; protein expression; protein purification; small-angle X-ray scattering (SAXS)

Mesh:

Substances:

Year:  2019        PMID: 30842263      PMCID: PMC6497952          DOI: 10.1074/jbc.RA118.007204

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  100 in total

1.  Coarse-grained models for simulations of multiprotein complexes: application to ubiquitin binding.

Authors:  Young C Kim; Gerhard Hummer
Journal:  J Mol Biol       Date:  2007-11-28       Impact factor: 5.469

2.  Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

Authors:  Sharon Gauci; Andreas O Helbig; Monique Slijper; Jeroen Krijgsveld; Albert J R Heck; Shabaz Mohammed
Journal:  Anal Chem       Date:  2009-06-01       Impact factor: 6.986

3.  Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells.

Authors:  Christoph Weber; Thiemo B Schreiber; Henrik Daub
Journal:  J Proteomics       Date:  2011-11-15       Impact factor: 4.044

4.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  Profilin reduces aggregation and phase separation of huntingtin N-terminal fragments by preferentially binding to soluble monomers and oligomers.

Authors:  Ammon E Posey; Kiersten M Ruff; Tyler S Harmon; Scott L Crick; Aimin Li; Marc I Diamond; Rohit V Pappu
Journal:  J Biol Chem       Date:  2018-01-22       Impact factor: 5.157

6.  System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

Authors:  Kristoffer T G Rigbolt; Tatyana A Prokhorova; Vyacheslav Akimov; Jeanette Henningsen; Pia T Johansen; Irina Kratchmarova; Moustapha Kassem; Matthias Mann; Jesper V Olsen; Blagoy Blagoev
Journal:  Sci Signal       Date:  2011-03-15       Impact factor: 8.192

7.  Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas.

Authors:  Delphine Rolland; Venkatesha Basrur; Kevin Conlon; Thomas Wolfe; Damian Fermin; Alexey I Nesvizhskii; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  Am J Pathol       Date:  2014-03-22       Impact factor: 4.307

8.  Network organization of the huntingtin proteomic interactome in mammalian brain.

Authors:  Dyna I Shirasaki; Erin R Greiner; Ismael Al-Ramahi; Michelle Gray; Pinmanee Boontheung; Daniel H Geschwind; Juan Botas; Giovanni Coppola; Steve Horvath; Joseph A Loo; X William Yang
Journal:  Neuron       Date:  2012-07-12       Impact factor: 17.173

9.  Phosphoproteome of resting human platelets.

Authors:  René P Zahedi; Urs Lewandrowski; Julia Wiesner; Stefanie Wortelkamp; Jan Moebius; Claudia Schütz; Ulrich Walter; Stepan Gambaryan; Albert Sickmann
Journal:  J Proteome Res       Date:  2007-12-19       Impact factor: 4.466

10.  Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets.

Authors:  David Britton; Yoh Zen; Alberto Quaglia; Stefan Selzer; Vikram Mitra; Christopher Löβner; Stephan Jung; Gitte Böhm; Peter Schmid; Petra Prefot; Claudia Hoehle; Sasa Koncarevic; Julia Gee; Robert Nicholson; Malcolm Ward; Leandro Castellano; Justin Stebbing; Hans Dieter Zucht; Debashis Sarker; Nigel Heaton; Ian Pike
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

View more
  9 in total

1.  Inhibition of p38 Mitogen-Activated Protein Kinase Ameliorates HAP40 Depletion-Induced Toxicity and Proteasomal Defect in Huntington's Disease Model.

Authors:  Zih-Ning Huang; Jie-Mao Chen; Liang-Ching Huang; Yi-Hsuan Fang; Lu-Shiun Her
Journal:  Mol Neurobiol       Date:  2021-01-25       Impact factor: 5.590

2.  Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease.

Authors:  Todd M Greco; Christopher Secker; Eduardo Silva Ramos; Joel D Federspiel; Jeh-Ping Liu; Alma M Perez; Ismael Al-Ramahi; Jeffrey P Cantle; Jeffrey B Carroll; Juan Botas; Scott O Zeitlin; Erich E Wanker; Ileana M Cristea
Journal:  Cell Syst       Date:  2022-02-10       Impact factor: 11.091

3.  Purification of Protein-complexes from the Cyanobacterium Synechocystis sp. PCC 6803 Using FLAG-affinity Chromatography.

Authors:  Minna M Koskela; Petra Skotnicová; Éva Kiss; Roman Sobotka
Journal:  Bio Protoc       Date:  2020-05-20

4.  Translation in amino-acid-poor environments is limited by tRNAGln charging.

Authors:  Bryan King; Rachel H Josselsohn; Natalya N Pavlova; Sara Violante; Victoria L Macera; Santosha A Vardhana; Justin R Cross; Craig B Thompson
Journal:  Elife       Date:  2020-12-08       Impact factor: 8.140

Review 5.  DNA Repair in Huntington's Disease and Spinocerebellar Ataxias: Somatic Instability and Alternative Hypotheses.

Authors:  Tamara Maiuri; Claudia L K Hung; Celeste Suart; Nola Begeja; Carlos Barba-Bazan; Yi Peng; Natasha Savic; Timothy Wong; Ray Truant
Journal:  J Huntingtons Dis       Date:  2021

6.  Sis1 potentiates the stress response to protein aggregation and elevated temperature.

Authors:  Courtney L Klaips; Michael H M Gropp; Mark S Hipp; F Ulrich Hartl
Journal:  Nat Commun       Date:  2020-12-08       Impact factor: 14.919

7.  Purification of full-length recombinant human huntingtin proteins with allelic series of polyglutamine lengths.

Authors:  Hyeongju Kim; Kyung-Gi Hyun; Alejandro Lloret; Ihn Sik Seong; Ji-Joon Song
Journal:  STAR Protoc       Date:  2021-10-16

Review 8.  Huntingtin and Its Partner Huntingtin-Associated Protein 40: Structural and Functional Considerations in Health and Disease.

Authors:  Manuel Seefelder; Fabrice A C Klein; Bernhard Landwehrmeyer; Rubén Fernández-Busnadiego; Stefan Kochanek
Journal:  J Huntingtons Dis       Date:  2022

Review 9.  Recent Microscopy Advances and the Applications to Huntington's Disease Research.

Authors:  Mouhanad Babi; Kaitlyn Neuman; Christina Y Peng; Tamara Maiuri; Celeste E Suart; Ray Truant
Journal:  J Huntingtons Dis       Date:  2022
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.